Unknown

Dataset Information

Risks of using mitoquinone during in vitro maturation and its potential protective effects against lipotoxicity-induced oocyte mitochondrial stress.


ABSTRACT:

Purpose

Oxidative stress and mitochondrial dysfunction play central roles in reduced oocyte quality and infertility in obese patients. Mitochondria-targeted treatments containing co-enzyme Q10 such as mitoquinone (MitoQ) can increase mitochondrial antioxidative capacity; however, their safety and efficiency when supplemented to oocytes under lipotoxic conditions have not been described.

Methods

We tested the effect of different concentrations of MitoQ or its cationic carrier (TPP) (0, 0.1, 0.5, 1.0 μM each) during bovine oocyte IVM. Then, we tested the protective capacity of MitoQ (0.1 μM) against palmitic acid (PA)-induced lipotoxicity and mitochondrial dysfunction in oocytes.

Results

Exposure to MitoQ, or TPP only, at 1 μM significantly (P<0.05) reduced oocyte mitoc

SUBMITTER: Marei WFA 

PROVIDER: S-EPMC10894804 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature